30 March 2011
Hamlet Protein has commenced a multi-million dollar investment in a new US sales and production company on the back of strong sales growth in the North American market. Employing an initial 25 members of staff, the US organisation will be responsible for serving customers in the entire NAFTA region.
Located in Findlay, Ohio, the new production plant is expected to go into operation in early 2012, combining Hamlet Protein's unique bio-based technology with raw materials supplied by the area's large soya-farming community. The bioconversion technology from Hamlet Protein is based on minimum energy consumption, no use of chemicals in the manufacturing process and minimum of waste.
See full press release (English only)